SLC7A11 and glioblastoma: We propose a model based on the experimental data we obtained above to demonstrate how IDO1-Kyn-AhR axis negatively regulates the FTO expression and subsequently increases the m6A deposition to improve SLC7A11 mRNA stability and expression, thereby inhibiting ferroptosis in GBM cells (Fig. 6).